Neurocritical Care News

Neurotechnology firm Kernel and biopharmaceutical company Cybin announced promising pilot results from a feasibility study of Kernel Flow, a technology that measures brain activity in altered states of consciousness.

Stealth BioTherapeutics Corp. announced that the FDA has granted orphan drug designation to elamipretide for the treatment of Duchenne muscular dystrophy.

People with higher levels of antioxidants in their blood may be less likely to develop dementia, researchers reported in Neurology.

In a company press release, Blackrock Neurotech announced the acquisition of spatial computing software firm MindX to bolster its development of technologically advanced brain-computer interface products.

The FDA has approved Neuronetics’ transcranial magnetic stimulation system, called NeuroStar, as an adjunct treatment for adults with obsessive compulsive disorder.

In-hospital outcomes for acute ischemic stroke patients with solid organ malignancy varied depending on the type of cancer and use of stroke interventions, according to a study published in Neurology.

Digital therapeutics company Big Health has announced a partnership with the University of Oxford for a new study evaluating Sleepio, an online program designed to improve sleep and mental health for stroke patients.

PHILADELPHIA — Diffuse axonal injury-type lesions in postoperative MRI can predict poor outcomes for children with severe traumatic brain injury, a presenter said at the American Association of Neurological Surgeons annual meeting.

Patients with Lennox-Gastaut syndrome experienced a significant reduction in drop seizures with fenfluramine, according to results of a clinical trial published in JAMA Neurology.

TecTraum Inc. announced complete enrollment status for a clinical trial evaluating its pro2cool device, a noninvasive hypothermic therapy system for treating concussions.